Showing 1 - 12 results of 12 for search 'Yeonhee Kim', query time: 0.74s
Refine Results
-
1
Automated Memory Corruption Detection through Analysis of Static Variables and Dynamic Memory Usage by Jihyun Park, Byoungju Choi, Yeonhee Kim
Published 2021-09-01
Article -
2
Supplementation with High or Low Iron Reduces Colitis Severity in an AOM/DSS Mouse Model by Seonghwan Moon, Minju Kim, Yeonhee Kim, Seungmin Lee
Published 2022-05-01
Article -
3
-
4
-
5
Effects of Sodium Selenite Injection on Serum Metabolic Profiles in Women Diagnosed with Breast Cancer-Related Lymphedema—Secondary Analysis of a Randomized Placebo-Controlled Tria... by Heeju Lee, Bora Lee, Yeonhee Kim, Sohyun Min, Eunjoo Yang, Seungmin Lee
Published 2021-09-01
Article -
6
-
7
-
8
P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA by Sojeong Kim, June-Young Koh, Haerim Chung, Yeonhee Kim, Eui-Cheol Shin, Jeong Seok Lee, Jin Seok Kim, Hyunsoo Cho
Published 2023-08-01
Article -
9
747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors by Joal D Beane, Yazan Samhouri, Brent A Hanks, John Hyngstrom, Sarah Weiss, Heidi Gillenwater, Yeonhee Kim, J Randolph Hecht, Bishwa J Ganguly, Hajime Hiraragi, Lucy Gong, Navid Nikoo
Published 2023-11-01Article -
10
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma by Jennifer Wu, June-Won Cheong, Eui-Cheol Shin, Yu Ri Kim, Hyunsoo Cho, Yeonhee Kim, Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Chung Hyun Park, Jin Seok Kim
Published 2024-01-01
Article -
11
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia by Steven E. Coutre, Ian W. Flinn, Sven de Vos, Jacqueline C. Barrientos, Marshall T. Schreeder, Nina D. Wagner-Johnson, Jeff P. Sharman, Thomas E. Boyd, Nathan Fowler, Lyndah Dreiling, Yeonhee Kim, Siddhartha Mitra, Kanti Rai, John P. Leonard, Richard R. Furman
Published 2018-06-01
Article -
12
754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small c... by Haven Garber, Saranya Chumsri, Yazan Migdady, Chul Kim, Erika Hamilton, Jennifer Specht, Babar Bashir, Hirva Mamdani, Heidi Gillenwater, Yeonhee Kim, David R Spigel, Usama Gergis, Hemant S Murthy, Lubna N Chaudhary, Sarah Fitzsimmons, Bishwa J Ganguly, Hajime Hiraragi, Helle Jensen, Mary C Lessig
Published 2023-11-01Article